We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SLRX market cap is 2.09M. The company's latest EPS is USD -8.7034 and P/E is -0.17.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.97M | -2.53M | -971k | -1.77M | -1.47M |
| Net Income | -3.88M | -2.44M | -882k | -1.72M | -1.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.47M | 5.23M | 1.84M | 0 | 0 |
| Operating Income | -8.27M | -7.79M | -12.81M | -31.84M | -12.9M |
| Net Income | -6.94M | -7.75M | -12.77M | -31.61M | -12.54M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.06M | 8.4M | 6.59M | 4.88M | 3.55M |
| Total Liabilities | 3.64M | 2.32M | 1.3M | 1.23M | 1.18M |
| Total Equity | 8.41M | 6.08M | 5.29M | 3.65M | 2.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.89M | 24.93M | 40.83M | 14.65M | 6.59M |
| Total Liabilities | 3.31M | 2.77M | 2.11M | 4.27M | 1.3M |
| Total Equity | 10.58M | 22.16M | 38.72M | 10.39M | 5.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.59M | -11.34M | -12.85M | -1.35M | -2.43M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 7.02M | 6.81M | 6.64M | -173k | -201k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.58M | -10.31M | -10.2M | -17.6M | -12.85M |
| Investing | 5.61M | -3k | N/A | -1.5M | N/A |
| Financing | 3.58M | 17.69M | 28.3M | 1.99M | 6.64M |
| Market Cap | 2.09M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.37 |
| Price to Book Ratio | 0.41 |
| Dividend Yield | - |
| Shares Outstanding | 1.44M |
| Average Volume (1 week) | 17.12k |
| Average Volume (1 Month) | 25.4k |
| 52 Week Change | -71.90% |
| 52 Week High | 7.20 |
| 52 Week Low | 1.26 |
| Spread (Intraday) | 0.06 (3.97%) |
| Company Name | Salarius Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.flex-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
